Basel Medical Group Ltd
Income Statement
| Line Item | FY2025 |
|---|---|
| Revenue | $8.9M |
| Cost of Revenue | — |
| Gross Profit | — |
| Gross Margin | — |
| Operating Expenses | |
| Research & Development | — |
| SG&A Expense | — |
| Operating Income | $-8.7M |
| Operating Margin | -97.6% |
| Interest Expense | — |
| Pretax Income | $-8.7M |
| Income Tax Expense | $-328.2K |
| Net Income | $-8.4M |
| Net Margin | -94.0% |
| EPS (Basic) | $-0.45 |
| EPS (Diluted) | $-0.45 |
| Shares Outstanding (Basic) | 18.8M |
| Shares Outstanding (Diluted) | 18.8M |
| Dividends Per Share | — |